GPI S p A (GPI) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
7 Oct, 2025Business overview and strategy
Delivers digital healthcare solutions with a focus on sustainability and cost reduction, operating through strategic business areas (SBAs) tailored to healthcare complexity.
Software SBA achieved a 23.4% CAGR from 2021–2024, driven equally by organic and inorganic growth.
Care SBA (BPO services) provides access to 30 million Italians and supports market access and customer engagement.
Strategic plan 2025–2029 focuses on consolidating software leadership, leveraging acquisitions, expanding internationally, and diversifying into telemedicine, cyberdefence, and automation.
Targets for 2029 include revenue over €700m (27–30% international), EBITDA margin above 25%, and NFP/EBITDA below 2.5x.
Financial performance
FY2024 revenue reached €509.9m (+17.7%), with software contributing €304.1m (+33.7%).
EBITDA rose to €104.8m (+31.3%), with a margin of 20.6% (+220bps YoY); EBIT increased to €36.7m (+43.4%).
Net income from continuing operations was €14.6m, and total net income was €103.4m.
Net financial indebtedness decreased by €32.2m to €332.7m, supported by strong cash generation and reduced financial expenses.
Approved ordinary dividend of €0.50 per share for FY2024.
Market position and growth
Market leader in Italian healthcare software and BPO, with growing international presence; 33% of software revenue is international.
Offices in 18 countries, serving over 70 countries globally.
Software segment shows high retention (96%) and win ratio (44%), with 79% public and 21% private customers.
Major product lines include Hospital Information Systems, Blood management, Diagnostics, Telemedicine, and Critical Care.
Success in all major Italian public health digitization tenders, often ranking first.
Latest events from GPI S p A
- Aims for €700m+ revenue and >25% EBITDA margin by 2029, with global digital and ESG focus.GPI
Investor Update9 Jul 2026 - FY24 saw 18% revenue growth, 31% EBITDA rise, and a strong outlook to 2029.GPI
H2 2024 & CMD 20258 Jul 2026 - 2025 revenue rose 7% to €546.2M, with software and international markets driving growth.GPI
H2 202531 Mar 2026 - Strong H1 2024 revenue and EBITDA growth, with record net income and extraordinary dividend.GPI
H1 202419 Jan 2026 - H1 2025 revenue up 9.1% and EBITDA up 14.8%, driven by software and global expansion.GPI
H1 202517 Dec 2025 - Double-digit growth in FY23, led by software and global expansion, with robust M&A activity.GPI
Investor Presentation7 Oct 2025 - Double-digit revenue and EBITDA growth in H1 2024, fueled by digital health and global expansion.GPI
Investor Presentation7 Oct 2025